tiprankstipranks
Molecular Templates Inc (MTEM)
NASDAQ:MTEM
US Market
Holding MTEM?
Track your performance easily

Molecular Templates (MTEM) Income Statement

551 Followers

Molecular Templates Income Statement

Last quarter (Q2 2024), Molecular Templates's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Molecular Templates's net income was $-8.10M. See Molecular Templates’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 19.00M$ 52.63M$ 19.75M--$ 138.00K
Cost of Revenue
------
Gross Profit
$ 52.63M$ 52.63M---$ 138.00K
Operating Expense
$ 47.12M$ 63.09M$ 108.63M$ 118.77M$ 119.69M$ 92.72M
Operating Income
$ -30.55M$ -10.47M$ -88.87M$ -80.07M$ -100.84M$ -92.72M
Net Non Operating Interest Income Expense
$ 1.12M$ 1.45M$ 3.73M$ 434.00K$ 1.03M$ 2.32M
Other Income Expense
$ 39.83M$ 3.78M$ -66.00K$ -38.70M$ -15.45M$ -20.98M
Pretax Income
$ -26.26M$ -8.13M$ -92.67M$ -83.01M$ -104.91M$ -69.42M
Tax Provision
$ -11.00K$ -11.00K$ 53.00K$ -3.83M$ 5.00K-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -27.07M$ -8.12M$ -92.72M$ -83.01M$ -104.92M$ -69.42M
Basic EPS
$ -5.88$ -1.80$ 24.75$ 22.50$ 33.00-
Diluted EPS
$ -5.88$ -1.80$ 24.75$ 22.50$ 33.00$ 27.90
Basic Average Shares
$ 20.81M$ 4.50M$ 3.76M$ 3.69M$ 3.17M$ 2.52M
Diluted Average Shares
$ 20.81M$ 4.50M$ 3.76M$ 3.69M$ 3.17M$ 2.52M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 47.12M$ 63.09M$ 108.63M$ 118.77M$ 119.69M$ 92.72M
Net Income From Continuing And Discontinued Operation
$ -27.07M$ -8.12M$ -92.72M$ -83.01M$ -104.92M$ -69.42M
Normalized Income
$ -15.29M$ -7.39M----
Interest Expense
------
EBIT
$ -27.01M$ -5.48M$ -87.95M$ -79.64M$ -103.21M$ -69.42M
EBITDA
$ -21.09M$ 1.16M$ -80.57M$ -73.01M$ -99.29M$ -67.75M
Currency in USD

Molecular Templates Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis